The Crystal Structure of Mouse Ces2c, a Potential Ortholog of Human CES2, Shows Structural Similarities in Substrate Regulation and Product Release to Human CES1.

X-ray crystallography biochemistry carboxylesterase 2c lipid hydrolysis lipid metabolism molnupiravir non-alcoholic fatty liver disease protein structure α/β-hydrolase fold

Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
28 Oct 2022
Historique:
received: 29 09 2022
revised: 17 10 2022
accepted: 20 10 2022
entrez: 11 11 2022
pubmed: 12 11 2022
medline: 15 11 2022
Statut: epublish

Résumé

Members of the carboxylesterase 2 (Ces2/CES2) family have been studied intensively with respect to their hydrolytic function on (pro)drugs, whereas their physiological role in lipid and energy metabolism has been realized only within the last few years. Humans have one CES2 gene which is highly expressed in liver, intestine, and kidney. Interestingly, eight homologous Ces2 (Ces2a to Ces2h) genes exist in mice and the individual roles of the corresponding proteins are incompletely understood. Mouse Ces2c (mCes2c) is suggested as potential ortholog of human CES2. Therefore, we aimed at its structural and biophysical characterization. Here, we present the first crystal structure of mCes2c to 2.12 Å resolution. The overall structure of mCes2c resembles that of the human CES1 (hCES1). The core domain adopts an α/β hydrolase-fold with S230, E347, and H459 forming a catalytic triad. Access to the active site is restricted by the cap, the flexible lid, and the regulatory domain. The conserved gate (M417) and switch (F418) residues might have a function in product release similar as suggested for hCES1. Biophysical characterization confirms that mCes2c is a monomer in solution. Thus, this study broadens our understanding of the mammalian carboxylesterase family and assists in delineating the similarities and differences of the different family members.

Identifiants

pubmed: 36361897
pii: ijms232113101
doi: 10.3390/ijms232113101
pmc: PMC9655854
pii:
doi:

Substances chimiques

Carboxylic Ester Hydrolases EC 3.1.1.-
Carboxylesterase EC 3.1.1.1
CES1 protein, human EC 3.1.1.1
CES2 protein, human EC 3.1.1.1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : FWF Austrian Science Fund
ID : F73
Organisme : FWF Austrian Science Fund
ID : DOC 50
Organisme : FWF Austrian Science Fund
ID : DOC 130
Organisme : State of Styria
ID : N/A
Organisme : City of Graz
ID : N/A

Références

Acta Crystallogr D Struct Biol. 2018 Feb 1;74(Pt 2):143-151
pubmed: 29533240
Acta Crystallogr D Biol Crystallogr. 2011 Apr;67(Pt 4):386-94
pubmed: 21460457
Nat Struct Biol. 2003 May;10(5):349-56
pubmed: 12679808
Biochem Pharmacol. 2018 Sep;155:233-241
pubmed: 30006193
Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2126-32
pubmed: 15572765
Clin Cancer Res. 2003 Oct 15;9(13):4983-91
pubmed: 14581373
Annu Rev Pharmacol Toxicol. 1998;38:257-88
pubmed: 9597156
Metabolites. 2020 Apr 10;10(4):
pubmed: 32290093
Antimicrob Agents Chemother. 2021 Aug 17;65(9):e0060221
pubmed: 34125594
Int J Biol Macromol. 2019 Sep 15;137:261-269
pubmed: 31260759
Am J Physiol Gastrointest Liver Physiol. 2021 Jan 1;320(2):G166-G174
pubmed: 33325808
Biochemistry. 2007 May 1;46(17):5063-71
pubmed: 17407327
Protein Sci. 2018 Jan;27(1):293-315
pubmed: 29067766
J Affect Disord. 2016 Jul 01;198:222-9
pubmed: 27031289
Methods. 2011 Sep;55(1):94-106
pubmed: 21821126
Science. 2015 Jan 23;347(6220):1260419
pubmed: 25613900
Antimicrob Agents Chemother. 2018 Jul 27;62(8):
pubmed: 29891600
Nucleic Acids Res. 2021 Jan 8;49(D1):D1388-D1395
pubmed: 33151290
J Mol Biol. 2006 Oct 13;363(1):201-14
pubmed: 16962139
Nat Struct Mol Biol. 2021 Sep;28(9):740-746
pubmed: 34381216
J Mol Biol. 2005 Sep 9;352(1):165-77
pubmed: 16081098
Chem Biol. 2003 Apr;10(4):341-9
pubmed: 12725862
Mol Pharmacol. 2010 Apr;77(4):508-16
pubmed: 20051531
Eur J Pharm Sci. 2020 Sep 1;152:105455
pubmed: 32629019
J Med Chem. 2006 Oct 19;49(21):6177-96
pubmed: 17034125
Hepatol Commun. 2018 Dec 17;3(2):227-245
pubmed: 30766961
Hepatology. 2016 Jun;63(6):1860-74
pubmed: 26806650
Cell Rep. 2017 Jan 17;18(3):636-646
pubmed: 28099843
J Lipid Res. 2021;62:100075
pubmed: 33872605
J Med Chem. 2004 Mar 25;47(7):1739-49
pubmed: 15027865
Int J Mol Sci. 2021 Apr 26;22(9):
pubmed: 33925827
Hepatology. 2020 Sep;72(3):1117-1126
pubmed: 32236963
Crit Rev Food Sci Nutr. 2021;61(13):2262-2276
pubmed: 32539446
Drug Metab Dispos. 2013 Jan;41(1):40-9
pubmed: 23011759
FEBS J. 2020 Mar;287(5):1035-1053
pubmed: 31545554
Biochimie. 2020 Feb;169:62-68
pubmed: 31404588
PLoS One. 2015 Dec 11;10(12):e0143919
pubmed: 26657071
Protein Cell. 2018 Feb;9(2):178-195
pubmed: 28677105
J Appl Crystallogr. 2021 Feb 01;54(Pt 1):343-355
pubmed: 33833657
Nat Struct Biol. 2002 May;9(5):337-42
pubmed: 11967565
Drug Metab Dispos. 2022 Sep;50(9):1151-1160
pubmed: 35790245
Mamm Genome. 2010 Oct;21(9-10):427-41
pubmed: 20931200
Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):125-32
pubmed: 20124692
Drug Metab Rev. 2007;39(1):1-15
pubmed: 17364878
Sci Transl Med. 2022 Jan 19;14(628):eabl7430
pubmed: 34941423
Arch Biochem Biophys. 2003 Aug 1;416(1):101-9
pubmed: 12859986
Acta Crystallogr D Struct Biol. 2018 Jun 1;74(Pt 6):519-530
pubmed: 29872003
Acta Pharm Sin B. 2018 Sep;8(5):699-712
pubmed: 30245959
Antimicrob Agents Chemother. 2021 Mar 1;:
pubmed: 33649113

Auteurs

Helgit Eisner (H)

Institute of Molecular Biosciences, University of Graz, 8010 Graz, Austria.

Lina Riegler-Berket (L)

Institute of Molecular Biosciences, University of Graz, 8010 Graz, Austria.

Carlos Francisco Rodriguez Gamez (CFR)

Institute of Molecular Biosciences, University of Graz, 8010 Graz, Austria.

Theo Sagmeister (T)

Institute of Molecular Biosciences, University of Graz, 8010 Graz, Austria.

Gabriel Chalhoub (G)

Institute of Molecular Biosciences, University of Graz, 8010 Graz, Austria.

Barbara Darnhofer (B)

Diagnostic and Research Institute of Pathology, Medical University of Graz, 8010 Graz, Austria.
BioTechMed Graz, 8010 Graz, Austria.

P J Jazleena (PJ)

Institute of Molecular Biosciences, University of Graz, 8010 Graz, Austria.

Ruth Birner-Gruenberger (R)

Diagnostic and Research Institute of Pathology, Medical University of Graz, 8010 Graz, Austria.
BioTechMed Graz, 8010 Graz, Austria.
Institute of Chemical Technologies and Analytics, Faculty of Technical Chemistry, Technische Universität Wien, 1060 Vienna, Austria.

Tea Pavkov-Keller (T)

Institute of Molecular Biosciences, University of Graz, 8010 Graz, Austria.
BioTechMed Graz, 8010 Graz, Austria.
BioHealth Field of Excellence, University of Graz, 8010 Graz, Austria.

Guenter Haemmerle (G)

Institute of Molecular Biosciences, University of Graz, 8010 Graz, Austria.
BioTechMed Graz, 8010 Graz, Austria.
BioHealth Field of Excellence, University of Graz, 8010 Graz, Austria.

Gabriele Schoiswohl (G)

BioTechMed Graz, 8010 Graz, Austria.
BioHealth Field of Excellence, University of Graz, 8010 Graz, Austria.
Institute of Pharmaceutical Sciences, Pharmacology & Toxicology, University of Graz, 8010 Graz, Austria.

Monika Oberer (M)

Institute of Molecular Biosciences, University of Graz, 8010 Graz, Austria.
BioTechMed Graz, 8010 Graz, Austria.
BioHealth Field of Excellence, University of Graz, 8010 Graz, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH